Article info
Intraocular infection and inflammation
Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis
- Correspondence to Professor Xiaoyan Ding, Sun Yat-Sen University Zhongshan Ophthalmic Center State Key Laboratory of Ophthalmology, Guangzhou 510060, China; dingxy75{at}gmail.com
Citation
Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis
Publication history
- Received July 18, 2022
- Accepted November 27, 2022
- First published January 3, 2023.
Online issue publication
January 29, 2024
Article Versions
- Previous version (29 January 2024).
- Previous version (29 January 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.